267 results
Page 5 of 14
8-K
EX-99.2
d835l555zg1
26 Jan 12
Net Sales Rise 7% to $5.5 Billion in Fourth Quarter
12:00am
8-K
EX-99.1
5escn xlx74sq5x
26 Jan 12
Net Sales Rise 7% to $5.5 Billion in Fourth Quarter
12:00am
SC TO-T
EX-99
qrdj5 tbm8zg
13 Jan 12
Third party tender offer statement
12:00am
8-K
EX-99.1
lplahdqnhltfwwwg7u
27 Oct 11
Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development
12:00am
8-K
EX-99.1
mcuz7fz
28 Jul 11
Important Clinical Data and Strong Financial Results
12:00am
8-K
EX-99.1
17kqlzuc53qd14d
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.1
gm2k24k
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am